I'm thrilled to sit down with Dr. Ivan Kairatov, a renowned interventional cardiologist and senior scientist at the Population Health Research Institute. With his extensive expertise in heart attack treatment strategies, Dr. Kairatov has been at the forefront of groundbreaking research on complete
The intersection of artificial intelligence and synthetic biology has unlocked groundbreaking possibilities, but it also casts a dark shadow over global biosecurity, as highlighted in a pivotal study recently published in Science . This research reveals how AI-powered generative protein design
In the intricate world of cellular biology, a silent player often dictates the fate of health and disease: enzymes that modify proteins on a molecular level, shaping their function in profound ways. One such enzyme, N-acetylglucosaminyltransferase-V, commonly referred to as GnT-V or MGAT5, has
I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with a wealth of experience in research and development, particularly in the intersection of technology and innovation in the industry. Today, we’re diving into a fascinating area of study: the protective effects of maternal
Autism Spectrum Disorder (ASD) has traditionally been understood as a condition manifesting in early childhood, yet a pioneering study from the University of Cambridge is turning this perspective on its head with revelations about the genetic and developmental differences tied to the timing of
In a significant leap forward for prostate cancer research, a recent study published in Nature Genetics on November 5 has spotlighted PTGES3 (Prostaglandin E Synthase 3) as a pivotal regulator of the androgen receptor (AR), a protein deeply implicated in the disease’s progression. Conducted by
In the realm of virology, understanding how viruses interact with host cells is paramount to developing effective treatments and preventive measures, particularly for respiratory pathogens like the influenza A virus, which poses significant public health challenges. Traditional two-dimensional (2D)
In a world where obesity and type 2 diabetes affect millions, GLP-1 receptor agonists have emerged as transformative treatments, offering hope for better health outcomes. Yet, amidst their widespread adoption, a pressing concern lingers: could these powerful drugs, designed to regulate blood sugar
What if a simple combination of daily choices and modern medicine could halve the risk of heart attacks for millions living with Type 2 diabetes? Across the United States, where this condition affects over 30 million people, cardiovascular disease remains the leading cause of death for those
In the rapidly advancing field of cancer treatment, chimeric antigen receptor natural killer (CAR-NK) cell therapies stand out as a groundbreaking approach, offering scalable, off-the-shelf solutions that could transform patient care. These therapies, often developed from induced pluripotent stem
